Abbott Glucose Monitor Gets European Approval
September 28 2020 - 9:41AM
Dow Jones News
By Matt Grossman
Abbott Laboratories said Monday that its FreeStyle Libre 3
glucose-monitoring system has received approval for use in
Europe.
The system includes a small sensor that is applied to the back
of the upper arm and worn for 14 days at a time, Abbott said. The
sensor interacts with a mobile app to help people with diabetes
monitor their glucose levels.
Abbott, based in Illinois, said it will launch the system in
Europe in the coming months.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
September 28, 2020 09:26 ET (13:26 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Abbott Laboratories (NYSE:ABT)
Historical Stock Chart
From Apr 2023 to Apr 2024
